1. Home
  2. TIL vs HYMC Comparison

TIL vs HYMC Comparison

Compare TIL & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • HYMC
  • Stock Information
  • Founded
  • TIL 2018
  • HYMC N/A
  • Country
  • TIL United States
  • HYMC United States
  • Employees
  • TIL N/A
  • HYMC N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • HYMC Precious Metals
  • Sector
  • TIL Health Care
  • HYMC Basic Materials
  • Exchange
  • TIL Nasdaq
  • HYMC Nasdaq
  • Market Cap
  • TIL 230.1M
  • HYMC 75.4M
  • IPO Year
  • TIL 2021
  • HYMC N/A
  • Fundamental
  • Price
  • TIL $23.81
  • HYMC $3.14
  • Analyst Decision
  • TIL Buy
  • HYMC
  • Analyst Count
  • TIL 5
  • HYMC 0
  • Target Price
  • TIL $119.00
  • HYMC N/A
  • AVG Volume (30 Days)
  • TIL 334.3K
  • HYMC 837.0K
  • Earning Date
  • TIL 08-12-2025
  • HYMC 08-05-2025
  • Dividend Yield
  • TIL N/A
  • HYMC N/A
  • EPS Growth
  • TIL N/A
  • HYMC N/A
  • EPS
  • TIL N/A
  • HYMC N/A
  • Revenue
  • TIL N/A
  • HYMC N/A
  • Revenue This Year
  • TIL N/A
  • HYMC N/A
  • Revenue Next Year
  • TIL N/A
  • HYMC N/A
  • P/E Ratio
  • TIL N/A
  • HYMC N/A
  • Revenue Growth
  • TIL N/A
  • HYMC N/A
  • 52 Week Low
  • TIL $9.62
  • HYMC $1.95
  • 52 Week High
  • TIL $92.00
  • HYMC $4.70
  • Technical
  • Relative Strength Index (RSI)
  • TIL 45.83
  • HYMC 44.68
  • Support Level
  • TIL $20.60
  • HYMC $3.02
  • Resistance Level
  • TIL $31.67
  • HYMC $3.28
  • Average True Range (ATR)
  • TIL 3.53
  • HYMC 0.26
  • MACD
  • TIL -1.54
  • HYMC -0.04
  • Stochastic Oscillator
  • TIL 17.93
  • HYMC 30.51

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About HYMC Hycroft Mining Holding Corporation

Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.

Share on Social Networks: